---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-070970"
form_type: "8-K"
ticker: "PFSA"
cik: "0001859807"
company_name: "Profusa, Inc."
filed_at: "2026-06-23T17:00:24+00:00"
generated_at: "2026-06-23T17:01:13.841875+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Profusa shareholders approve reverse stock split, asset acquisition, and equity plan amendments

## Summary
- Elected Lauren Chung as Class I director with 631,502 FOR votes.
- Approved reverse stock split (1:5 to 1:200) at board's discretion through June 2028.
- Approved issuance of convertible preferred stock and common shares to Bio Insights LLC for PanOmics Assay acquisition.
- Approved potential >19.99% share issuance upon conversion of promissory note to NorthView Sponsor I LLC.
- Approved increase in 2025 Equity and Incentive Plan shares from 100,386 to 795,930.

## SEC filing metadata
- accession: 0001213900-26-070970
- form_type: 8-K
- ticker: PFSA
- cik: 0001859807
- company_name: Profusa, Inc.
- filed_at: 2026-06-23T17:00:24+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859807/000121390026070970/0001213900-26-070970-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859807/000121390026070970/ea0295656-8k_profusa.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-070970
- JSON: https://secwatch.observer/filing/0001213900-26-070970.json
- Plain text: https://secwatch.observer/filing/0001213900-26-070970.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.